A. Gabriella Wernicke, MD, MSc

home / authors / a-gabriella-wernicke-md-msc

Articles

A prospective trial may help affirm ctDNA as a non-invasive option of predicting responses to radiotherapy among those with gynecologic cancers.

ctDNA Data in Gynecologic Cancer RT Population May Be Hypothesis-Generating

A. Gabriella Wernicke, MD, MSc
October 21st 2024

A prospective trial may help affirm ctDNA as a non-invasive option of predicting responses to radiotherapy among those with gynecologic cancers.

ctDNA reductions or clearance also appeared to correlate with a decrease in disease burden during the pre-boost phase of radiotherapy.

ctDNA Clearance Confers Responses to Radiation in Gynecologic Malignancies

A. Gabriella Wernicke, MD, MSc
October 20th 2024

ctDNA reductions or clearance also appeared to correlate with a decrease in disease burden during the pre-boost phase of radiotherapy.

Investigators evaluated ctDNA as a potentially noninvasive method to predict response to radiotherapy among those with gynecologic malignancies.

Assessing ctDNA as a Predictor of RT Responses in Gynecologic Cancers

A. Gabriella Wernicke, MD, MSc
October 19th 2024

Investigators evaluated ctDNA as a potentially noninvasive method to predict response to radiotherapy among those with gynecologic malignancies.

Latest Updated Articles

NSABP B-42 trial results show that the assay was predictive of extended letrozole therapy response, identifying a patient subset with improved outcomes.
Published: August 9th 2024 | Updated: August 14th 2024
Gene Assay May Predict Extended Letrozole Benefits in Breast Cancer Subsets
OS Prolonged With Perioperative Chemo Vs Neoadjuvant CRT in Esophageal Cancer
Published: June 2nd 2024 | Updated: June 3rd 2024
OS Prolonged With Perioperative Chemo Vs Neoadjuvant CRT in Esophageal Cancer
Data from the CheckMate-67T trial support the biologics license application for subcutaneous nivolumab in multiple solid tumors.
Published: May 6th 2024 | Updated: May 21st 2024
FDA Accepts BLA for Subcutaneous Nivolumab in Solid Tumor Indications
A 78-Year-Old Woman With Nonpruritic Periorbital Purpura Around Her Eyelids
Published: August 13th 2011 | Updated: October 22nd 2024
A 78-Year-Old Woman With Nonpruritic Periorbital Purpura Around Her Eyelids
Patient With Supraglottic Squamous Cell Carcinoma Develops Painful Swelling on Both Great Toes
Published: August 26th 2011 | Updated: October 22nd 2024
Patient With Supraglottic Squamous Cell Carcinoma Develops Painful Swelling on Both Great Toes
Cancer rehabilitation medicine may help bridge a gap in oncology care, according to Jessica Cheng, MD.
Published: September 4th 2024 | Updated: October 22nd 2024
Cancer Rehabilitation Medicine: “Bridging the Gap” With Supportive Care